Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals.
Mellors J. et al, (2025), Nat Commun, 16
Asparagine availability controls germinal center B cell homeostasis.
Yazicioglu YF. et al, (2024), Sci Immunol, 9
Identifying falsified COVID-19 vaccines by analysing vaccine vial label and excipient profiles using MALDI-ToF mass spectrometry
Arman BY. et al, (2024), npj Vaccines
Concerted deletions eliminate a neutralizing supersite in SARS-CoV-2 BA.2.87.1 spike.
Duyvesteyn HME. et al, (2024), Structure, 32, 1594 - 1602.e6
COVID-19 vaccines are effective at preventing symptomatic and severe infection among healthcare workers: A clinical review.
Galgut O. et al, (2024), Vaccine X, 20
Immunogenicity of Abdala COVID-19 vaccine in Vietnamese people after primary and booster vaccinations: A prospective observational study in Vietnam.
Thanh TT. et al, (2024), Int J Infect Dis, 147
Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050.
GBD 2021 Antimicrobial Resistance Collaborators None., (2024), Lancet, 404, 1199 - 1226
Starvation and infection: The role of sickness-associated anorexia in metabolic adaptation during acute infection.
Jindal J. et al, (2024), Metabolism
Dysregulated immunologic landscape of the early host response in melioidosis.
Rongkard P. et al, (2024), JCI Insight, 9
Using matrix assisted laser desorption ionisation mass spectrometry combined with machine learning for vaccine authenticity screening
Clarke R. et al, (2024), npj Vaccines
Immunogenicity of COVID-19 vaccines in patients with follicular lymphoma receiving frontline chemoimmunotherapy.
Lim YJ. et al, (2024), Br J Haematol, 205, 440 - 451
Implications of suboptimal measles immunity in UK health-care workers.
Ho A. et al, (2024), Lancet, 404, 23 - 24
Diabetes and risk of hospitalisation due to infection in northeastern Thailand: Retrospective cohort study using population-based healthcare service data.
Peerawaranun P. et al, (2024), Diabet Med
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Goodyear CS. et al, (2024), Lancet Rheumatol, 6, e339 - e351
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.
GBD 2021 Demographics Collaborators None., (2024), Lancet, 403, 1989 - 2056
A structure-function analysis shows SARS-CoV-2 BA.2.86 balances antibody escape and ACE2 affinity.
Liu C. et al, (2024), Cell Rep Med